Ophthalmics
High-quality Compounded Ophthalmic
Sterile Preparations.
In an era of rapid regulatory change and heightened demand for high-quality compounded and repackaged drugs, Leiters, an FDA-registered 503B outsourcing facility, has emerged as a leader. Specializing in ophthalmology and hospital services, Leiters provides hospitals, surgery centers, clinics and physician offices access to high-quality compounded ophthalmic sterile preparations.
Leiters currently offers the following ophthalmic sterile preparations and services:
- FDA-compliant1 repackaged Avastin® service
- Moxifloxacin
- Lidocaine / Phenylephrine
- Cyclopentolate / Tropicamide / Phenylephrine
- Tropicamide / Phenylephrine
Interested in our full Leiters catalog? Download it here.
About Leiters
- Founded in 1926, Leiters is a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations.
- All sterile preparations are produced under 503B of the FD&C act (503B Guidance), Current Good Manufacturing Practices (cGMP) and USP <797>.
- Stability testing is performed prior to producing batches and full microbiological and chemistry testing is completed prior to releasing batches.
- A Certificate of Analysis (CoA), detailing the testing performed, is provided with every shipment.
- We are licensed to ship to all 50 states (+ the District of Columbia).
- Our ophthalmic sterile preparations have 90+ day Beyond Use Dates (BUD)2 .
- No patient prescription or name required.
Ophthalmic News and Resources
Leiters Health Industry Update on Repackaged Avastin®
Joseph Cosgrove appointed to Rowan’s Board of Trustees
Angels for Change Announces 2023 Project PROTECT Grant Award Winners
Leiters Health Ranks No. 2069 on the 2023 Inc. 5000
Leiters Unveils New Brand Identity Reflecting its Ongoing Commitment to Healthcare
1 Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application Guidance for Industry
2 BUD is from date compounded
3 Some exclusions apply. Contact customer service for more details
Avastin® is a registered trademark of Genentech, Inc.